Spleen plays an important role in the induction of accelerated blood clearance of PEGylated liposomes.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of Controlled Release

• Publication date

  2006-10-27

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.JCONREL.2006.08.001PMID 17011060
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hypersensitivity and loss of disease site targeting caused by antibody responses to PEGylated liposomes.

  2006cited by this paper
• A Case for Regulatory B Cells1

  2006cited by this paper
• Accelerated blood clearance of PEGylated liposomes upon repeated injections: effect of doxorubicin-encapsulation and high-dose first injection.

  2006cited by this paper
• Injection of PEGylated liposomes in rats elicits PEG-specific IgM, which is responsible for rapid elimination of a second dose of PEGylated liposomes.

  2006cited by this paper
• Immunogenicity and Rapid Blood Clearance of Liposomes Containing Polyethylene Glycol-Lipid Conjugates and Nucleic Acid

  2005cited by this paper
• Accelerated blood clearance of PEGylated liposomes following preceding liposome injection: effects of lipid dose and PEG surface-density and chain length of the first-dose liposomes.

  2005cited by this paper
• Influence of the physicochemical properties of liposomes on the accelerated blood clearance phenomenon in rats.

  2005cited by this paper
• Human innate B cells: a link between host defense and autoimmunity?

  2005cited by this paper
• Effect of the physicochemical properties of initially injected liposomes on the clearance of subsequently injected PEGylated liposomes in mice.

  2004cited by this paper
• Accelerated clearance of a second injection of PEGylated liposomes in mice.

  2003cited by this paper
• The interaction of liposomes with the complement system: in vitro and in vivo assays.

  2003cited by this paper
• Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties.

  2003cited by this paper
• Accelerated clearance of PEGylated liposomes in rats after repeated injections.

  2003cited by this paper
• Enhanced immune response to T-independent antigen by using CpG oligodeoxynucleotides encapsulated in liposomes.

  2001cited by this paper
• Complement activation-related pseudoallergy caused by liposomes, micellar carriers of intravenous drugs, and radiocontrast agents.

  2001cited by this paper
• Asplenic-hyposplenic Overwhelming Sepsis: Postsplenectomy Sepsis Revisited

  2001cited by this paper
• Factors affecting the accelerated blood clearance of polyethylene glycol-liposomes upon repeated injection.

  2001cited by this paper
• Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens.

  2001cited by this paper
• Accelerated blood clearance and altered biodistribution of repeated injections of sterically stabilized liposomes.

  2000cited by this paper
• Design of highly immunogenic liposomal constructs combining structurally independent B cell and T helper cell peptide epitopes

  1999cited by this paper
• Interaction of anti-cholesterol antibodies with human lipoproteins.

  1996cited by this paper
• Measurement of mouse anti-phospholipid antibodies to solid-phase microspheres by both flow cytofluorometry and Alcian blue-pretreated microtitre plates in an ELISA.

  1996cited by this paper
• Poly(ethylene glycol) on the liposome surface: on the mechanism of polymer-coated liposome longevity.

  1994cited by this paper
• Kinetic analysis of AUC-dependent saturable clearance of liposomes: Mathematical description of AUC dependency

  1993cited by this paper
• Postsplenectomy sepsis and its mortality rate: Actual versus perceived risks

  1991cited by this paper
• Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo.

  1991cited by this paper
• Immunoarchitecture of regenerated splenic and lymph node transplants.

  1991cited by this paper
• Influence of surface hydrophilicity of liposomes on their interaction with plasma protein and clearance from the circulation: studies with poly(ethylene glycol)-coated vesicles.

  1991cited by this paper
• Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy.

  1991cited by this paper
• Sterically stabilized liposomes: a hypothesis on the molecular origin of the extended circulation times.

  1991cited by this paper
• Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes

  1990cited by this paper
• Infection associated with asplenia: risks, mechanisms, and prevention.

  1990cited by this paper
• Immunoglobulins and complement in splenectomised and autotransplanted subjects.

  1989cited by this paper
• Lymphocyte and complement abnormalities in splenectomized patients with hematologic disorders

  1988cited by this paper
• The role of the spleen in resistance to infection.

  1986cited by this paper
• Thymus-independent antigens: complexity of B-lymphocyte activation revealed.

  1982cited by this paper
• The capacity and mechanism of bone marrow antibody formation by thymus-independent antigens.

  1982cited by this paper
• Colorimetric assay methods for free and phosphorylated glyceric acids.

  1959cited by this paper
• Reprints Available Directly from the Publisher Photocopying Permitted by License Only Plasma Gamma Globulin Levels after Splenectomy and Spleen Salvage

  year unknowncited by this paper

• Aptamer–liposome targeted nanotherapeutics for cancer therapy: Bibliometric analysis, recent developments and future perspectives

  2026cites this paper
• Considering the immunogenicity of PEG: strategies for overcoming issues with PEGylated nanomedicines

  2025cites this paper
• Triethylamine-mediated protonation–deprotonation unlocks dual-drug self assembly to suppress breast cancer progression and metastasis

  2025cites this paper
• A spleen-targeted vaccine for SARS-CoV-2 - inducting neutralizing antibodies in mice.

  2025cites this paper
• On the cellular selectivity of targeting peptide-nanoparticle conjugates – a nanoparticle perspective

  2025cites this paper
• Surface-engineered robust hybrid lipid nanocapsules: A next-generation nanoplatform for mRNA delivery.

  2025cites this paper
• Synergistic approach of PEGylated photothermal agent and immunomodulator in cancer immunotherapy.

  2025cites this paper
• Polyzwitterion-Based pH-Responsive Shell of Polymeric Micelle: Evaluation of Physicochemical Properties and In Vivo Functionalities.

  2025cites this paper
• Mitochondrial-Targeting Zwitterionic Nanomedicine Based on Tertiary Amine N-oxide Polymers for Triple-Negative Breast Cancer Therapy.

  2025cites this paper
• Pegylated cerasomes exhibit accelerated blood clearance in rats despite no elevation of anti-PEG IgM and IgG antibodies.

  2025cites this paper
• Cyclic Poly(2-methyl-2-oxazoline)-Lipid Conjugates Are Good Alternatives to Poly(ethylene glycol)-Lipids for Lipid Nanopartcile mRNA Formulation.

  2025cites this paper
• Neutrophils-mediated accelerated blood clearance phenomenon in beagles and rats based on the cross-injection of non-PEGylated and PEGylated nanoemulsions

  2025cites this paper
• Biomimetic approaches against accelerated blood clearance (ABC) phenomenon of nanoparticulate drug delivery systems.

  2025cites this paper
• Targeted nanoliposomes for precision rheumatoid arthritis therapy: a review on mechanisms and in vivo potential

  2025cites this paper
• Slow intravenous infusion reduces the accelerated blood clearance of PEGylated liposomes by removing anti-PEG antibodies.

  2025cites this paper
• Emerging strategies against accelerated blood clearance phenomenon of nanocarrier drug delivery systems

  2025cites this paper
• Poly(sarcosine) and Poly(2-ethyl-2-oxazoline) Tethered To mRNA Provide Stealth Properties To mRNA Polyplexes

  2025cites this paper
• Revealing the Incidence of the Accelerated Blood Clearance Phenomenon of PEGylated Liposomes in Individuals Using a Drug‐Release Reporter Liposome

  2025cites this paper
• Long circulating liposomal platform utilizing hydrophilic polymer-based surface modification: preparation, characterisation, and biological evaluation.

  2024cites this paper
• Mitigating the Effects of Persistent Antipolymer Immune Reactions in Nanomedicine: Evaluating Materials-Based Approaches Using Molecular Imaging.

  2024cites this paper
• Peritoneal B Cells Play a Role in the Production of Anti-polyethylene Glycol (PEG) IgM against Intravenously Injected siRNA-PEGylated Liposome Complexes.

  2024cites this paper
• Poly(N-acryloylmorpholine) Nanogels as Promising Materials for Biomedical Applications: Low Protein Adhesion and High Colloidal Stability

  2023cites this paper
• The interplay between PEGylated nanoparticles and blood immune system.

  2023cites this paper
• Anti-PEG IgM production induced by PEGylated liposomes as a function of administration route.

  2023cites this paper
• Controlling the biodistribution and clearance of nanomedicines

  2023cites this paper
• “Y-type” PEG modified liposomes could eliminate the accelerated blood clearance (ABC) phenomenon and improved tumor therapy

  2023cites this paper
• Visible Light-Conjugation with Triazolinediones as a Route to Degradable Poly(ethylene glycol)-Lipids for mRNA Lipid Nanoparticle Formulation.

  2023cites this paper
• PEGylated Lipid Nanoparticle Formulations: Immunological Safety and Efficiency Perspective

  2023cites this paper
• Tarin-Loaded Nanoliposomes Activate Apoptosis and Autophagy and Inhibit the Migration of Human Mammary Adenocarcinoma Cells

  2023cites this paper
• Polyplex Designs for Improving the Stability and Safety of RNA Therapeutics.

  2023cites this paper
• Activation of CYP3A by Accelerated Blood Clearance Phenomenon Potentiates the Hepatocellular Carcinoma-Targeting Therapeutic Effects of PEGylated Anticancer Prodrug Liposomes

  2023cites this paper
• Treatment-induced and pre-existing anti-PEG antibodies: Prevalence, clinical implications, and future perspectives.

  2023cites this paper
• Recent advances in nano-targeting drug delivery systems for rheumatoid arthritis treatment

  2023cites this paper
• Off Target Toxicities and Links with Physicochemical Properties of Medicinal Products, including Antibiotics, Oligonucleotides, Lipid nanoparticles (with cationic and/or anionic charges). Data review suggests an emerging pattern.

  2023cites this paper
• Investigation of anti-PEG antibody response to PEG-containing cosmetic products in mice.

  2023cites this paper
• Effects of PEG antibodies on in vivo performance of LNP-mRNA vaccines.

  2023cites this paper
• Interplay between Liposomes and IgM: Principles, Challenges, and Opportunities

  2023cites this paper
• Lipid‐Based Nanocarriers Enabled Oral Delivery of Oleanolic Acid Derivative DKS26 for Diabetes Management

  2023cites this paper
• PEGylated therapeutics in the clinic

  2023cites this paper
• Nucleic acid drug vectors for diagnosis and treatment of brain diseases

  2023cites this paper
• Liposome Nano-particles for Therapeutic and Diagnostic Applications

  2022cites this paper
• Liposomes trigger bone marrow niche macrophage “foam” cell formation and affect hematopoiesis in mice

  2022influential citation
• Liposomes: An emerging carrier for targeting Alzheimer's and Parkinson's diseases

  2022cites this paper
• Subvisible particles derived by dropping stress enhance anti-PEG antibody production and clearance of PEGylated proteins in mice.

  2022cites this paper
• Discovery in polyethylene glycol immunogenicity: the characteristic of intergenerational inheritance of anti-polyethylene glycol IgG.

  2022cites this paper
• Cell-based drug delivery systems and their in vivo fate.

  2022cites this paper
• Branched PEG-modification: A new strategy for nanocarriers to evade of the accelerated blood clearance phenomenon and enhance anti-tumor efficacy.

  2022cites this paper
• Can pulmonary RNA delivery improve our pandemic preparedness?

  2022cites this paper
• A Maleimide-Terminally Modified PEGylated Liposome Induced the Accelerated Blood Clearance Independent of the Production of Anti-PEG IgM Antibodies.

  2022cites this paper
• PEG: Will It Come Back to You? Polyethelyne Glycol Immunogenicity, COVID Vaccines, and the Case for New PEG Derivatives and Alternatives

  2022influential citation
• Polymer-Modified Liposomes for Drug Delivery: From Fundamentals to Applications

  2022cites this paper
• The mechanisms of anti-PEG immune response are different in the spleen and the lymph nodes.

  2022cites this paper
• Opsonin-Deficient Nucleoproteic Corona Endows UnPEGylated Liposomes with Stealth Properties In Vivo

  2022cites this paper
• Evaluation of the Antitumor Effect and Immune Response of Micelles Modified with a Polysialic Acid-d-α-Tocopheryl Polyethylene Glycol 1000 Succinate Conjugate

  2021cites this paper
• Polyethylene Glycol Immunogenicity: Theoretical, Clinical, and Practical Aspects of Anti-Polyethylene Glycol Antibodies.

  2021cites this paper
• Passive Targeting and the Enhanced Permeability and Retention (EPR) Effect

  2021cites this paper
• Targeted liposomal drug delivery: a nanoscience and biophysical perspective.

  2021cites this paper
• Polymeric Delivery of Therapeutic Nucleic Acids.

  2021cites this paper
• Systematic Review of Cancer Targeting by Nanoparticles Revealed a Global Association between Accumulation in Tumors and Spleen

  2021cites this paper
• Innate and adaptive immune responses toward nanomedicines

  2021cites this paper
• Glycolipid-Containing Nanoparticle Vaccine Engages Invariant NKT Cells to Enhance Humoral Protection against Systemic Bacterial Infection but Abrogates T-Independent Vaccine Responses

  2021cites this paper
• Immune Responses to PEGylated lipoplexes, a review

  2021cites this paper
• Incorporating Gangliosides into PEGylated Cationic Liposomes that Complexed DNA Attenuates Anti-PEG Antibody Production but Not Anti-DNA Antibody Production in Mice.

  2021cites this paper
• Clinical Relevance of Pre-Existing and Treatment-Induced Anti-Poly(Ethylene Glycol) Antibodies

  2021cites this paper
• Polymerized Albumin Receptor of Hepatitis B Virus for Evading the Reticuloendothelial System

  2021cites this paper
• Evasion of the accelerated blood clearance phenomenon by branched PEG lipid derivative coating of nanoemulsions.

  2021cites this paper
• Role of Stealth Lipids in Nanomedicine-based drug carriers.

  2021cites this paper
• Pegfilgrastim (PEG-G-CSF) Induces Anti-polyethylene Glycol (PEG) IgM via a T Cell-Dependent Mechanism.

  2020cites this paper
• Pre-treatment with high molecular weight free PEG effectively suppresses anti-PEG antibody induction by PEG-liposomes in mice.

  2020cites this paper
• Intravital imaging of liposome behavior upon repeated administration: A step towards the development of liposomal companion diagnostic for cancer nanotherapy.

  2020cites this paper
• Anti-PEG scFv corona ameliorates accelerated blood clearance phenomenon of PEGylated nanomedicines.

  2020cites this paper
• Anti-PEG antibodies: Properties, formation and role in adverse immune reactions to PEGylated nano-biopharmaceuticals.

  2020cites this paper
• Construction a Long-Circulating Delivery System of Liposomal Curcumin by Coating Albumin

  2020cites this paper
• Impact of pre-existing or induced anti-PEG IgM on the pharmacokinetics of peginterferon alfa-2a (Pegasys®) in mice.

  2020cites this paper
• Hepatosplenic phagocytic cells indirectly contribute to anti-PEG IgM production in the accelerated blood clearance (ABC) phenomenon against PEGylated liposomes: Appearance of an unexplained mechanism in the ABC phenomenon.

  2020cites this paper
• Application of nano-based systems for drug delivery and targeting: a review

  2020cites this paper
• Pegfilgrastim (PEG-G-CSF) induces anti-PEG IgM in a dose dependent manner and causes the accelerated blood clearance (ABC) phenomenon upon repeated administration in mice.

  2020cites this paper
• Immunogenicity of Polyethylene Glycol Based Nanomedicines: Mechanisms, Clinical Implications and Systematic Approach

  2020cites this paper
• Polymer-enhanced biomacromolecules

  2020cites this paper
• Virus like particles: fundamental concepts, biological interactions, and clinical applications

  2020cites this paper
• Heparan sulfate targeting strategy for enhancing liposomal drug accumulation and facilitating deep distribution in tumors

  2020cites this paper
• Immunological and Toxicological Considerations for the Design of Liposomes

  2020cites this paper
• PEGylation and Cell-Penetrating Peptides: Glimpse from Past and Prospects in Future.

  2020cites this paper
• ɑvβ3-targeted liposomal drug delivery system with attenuated immunogenicity enabled by linear pentapeptide for glioma therapy.

  2020cites this paper
• Natural IgM dominates in vivo performance of liposomes.

  2020cites this paper
• Physiologically Based Pharmacokinetic Modeling of Nanoparticles.

  2019cites this paper
• Overcoming anti-PEG antibody mediated accelerated blood clearance of PEGylated liposomes by pre-infusion with high molecular weight free PEG.

  2019cites this paper
• Poly(Sarcosine) Surface Modification Imparts Stealth-Like Properties to Liposomes.

  2019cites this paper
• PEGylated liposomes: immunological responses

  2019cites this paper
• Short Peptide-Mediated Brain-Targeted Drug Delivery with Enhanced Immunocompatibility.

  2019cites this paper
• Liposomes‐in‐Chitosan Hydrogels: Challenges and Opportunities for Biomedical Applications

  2019cites this paper
• Stromal Barriers Within the Tumor Microenvironment and Obstacles to Nanomedicine

  2019cites this paper
• Toxicity and immunogenicity concerns related to PEGylated-micelle carrier systems: a review

  2019cites this paper
• Non-immunogenic, low-toxicity and effective glioma targeting MTI-31 liposomes.

  2019cites this paper
• Overcoming Physiological Barriers to Nanoparticle Delivery—Are We There Yet?

  2019cites this paper
• Recent advances in porphyrin-based nanocomposites for effective targeted imaging and therapy.

  2019cites this paper
• Time Interval of Two Injections and First-Dose Dependent of Accelerated Blood Clearance Phenomenon Induced by PEGylated Liposomal Gambogenic Acid: The Contribution of PEG-Specific IgM.

  2019cites this paper
• Induction of Cytochrome P450 Involved in the Accelerated Blood Clearance Phenomenon Induced by PEGylated Liposomes In Vivo

  2019influential citation
• Anti-PEG IgM Production via a PEGylated Nanocarrier System for Nucleic Acid Delivery.

  2019cites this paper
• Diversity of PEGylation methods of liposomes and their influence on RNA delivery.

  2019cites this paper